AKTS
AKTS — Aktis Oncology, Inc.
CIK 2035832 · SEC EDGAR fundamentals
Headline figures
Revenue
—
Top-line sales for the most-recent fiscal year
Net income
—
Profit after all expenses, taxes, interest
EPS (diluted)
—
Net income per diluted share outstanding
Op. cashflow
—
Cash actually generated by the business
Balance sheet
Total assets
—
Everything the company owns
Total liabilities
—
Everything the company owes
Stockholders equity
—
Assets minus liabilities (book value)
Long-term debt
—
Debt due more than 12 months out
Data sources & methodology
- SEC EDGAR — official company filings (full-text search) ↗
- SEC EDGAR — institutional Form 13F holdings ↗
- U.S. House Clerk — Periodic Transaction Reports (Congress) ↗
All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →
TZ Researched & published by TradesZ Research
Not investment advice. Figures sourced from the SEC's XBRL CompanyFacts API — public-domain federal records. Companies occasionally restate prior-year numbers; we show the latest filed value per fiscal year.